BRAF mutation in papillary thyroid cancer-Prevalence and clinical correlation in a South-East Asian cohort.
Xueying GohJeffery LumSamantha Peiling YangSiok Bee ChionhEvelyn KoayLily ChiuRajeev ParameswaranKee Yuan NgiamThomas Kwok Seng LohMin En NgaChwee Ming LimPublished in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2018)
The prevalence of BRAF mutation is 56%. BRAF mutation-positive tumours were associated with locally advanced disease, but not poorer survival.